NASDAQ:KPTI | Cash Flow Statement | Karyopharm Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2011-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$67.02M
2026-03-31-$22.39M-$22.73M$3.2M$49.8M
2025-12-31-$102.2M-$11.83M$0.00$5M$29.69M
2025-09-30-$33.13M
2025-06-30-$37.25M
2025-03-31-$23.46M-$38.98M$0.00$15.29M$0.00
2024-12-31-$30.78M-$25.81M-$53,000.00$14.8M$680,000.00
2024-09-30-$32.07M
2024-06-30$23.79M
2024-03-31-$37.36M-$43.73M$195,000.00$21.94M
2023-12-31-$41.84M-$18.59M$0.00$26.84M$264,000.00
2023-09-30-$34.51M
2023-06-30-$32.63M
2023-03-31-$34.13M-$18.91M$0.00-$32.39M$0.00
2022-12-31-$38.51M-$26.84M$0.00-$65.3M$155.84M
2022-09-30-$36.32M
2022-06-30-$49.06M
2022-03-31-$41.4M-$59.2M$79,000.00-$14.04M$30.78M
2021-12-31$38.72M$25.48M$207,000.00$30.77M$896,000.00
2021-09-30-$51.81M
2021-06-30-$53.58M
2021-03-31-$57.41M-$52.89M$0.00$43.19M$10.68M
2020-12-31-$43.42M-$30.63M$119,000.00$31.4M$3.97M
2020-09-30-$53.5M
2020-06-30-$46.43M
2020-03-31-$52.93M-$45.01M$10,000.00-$46.48M$164.83M
2019-12-31-$48.65M-$39.49M$50,000.00-$33.52M$34.94M
2019-09-30-$41.37M
2019-06-30-$43.42M
2019-03-31-$66.16M-$66.62M$49,000.00$31.99M$152,000.00
2018-12-31-$58.21M-$48.17M$1.09M-$103.11M$167.78M
2018-09-30-$48.08M
2018-06-30-$33.66M
2018-03-31-$38.46M-$34.65M$382,000.00$2.48M$429,000.00
2017-12-31-$39.04M-$5.54M$55,000.00-$2.9M$22.96M
2017-09-30-$30.64M
2017-06-30-$29.39M
2017-03-31-$29.92M-$24.71M
2016-12-31-$26.94M-$20M$25,000.00
2016-09-30-$25.43M
2016-06-30-$30.16M
2016-03-31-$27.06M-$23.17M$39,000.00
2015-12-31-$29.05M-$20.38M$505,000.00
2015-09-30-$30.37M
2015-06-30-$32.7M
2015-03-31-$26.07M-$20.23M$178,000.00
2014-12-31-$25.93M-$12.77M$99,000.00
2014-09-30-$19.72M
2014-06-30-$16.43M
2014-03-31-$13.69M-$10.57M$125,000.00
2013-12-31-$10.08M$32,000.00
2013-03-31-$5.16M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$196.04M-$75.37M$0.00$43.38M$30.05M
2024-12-31-$76.42M-$127.49M$142,000.00$95.47M$41.65M
2023-12-31-$143.1M-$92.72M$0.00$7.94M$1.12M
2022-12-31-$165.29M-$149.55M$118,000.00-$104.26M$193.74M
2021-12-31-$124.09M-$107.12M$212,000.00$141.84M$73.65M
2020-12-31-$196.27M-$160.23M$145,000.00-$53.69M$172.08M
2019-12-31-$199.59M-$190.82M$206,000.00$78.45M$124.31M
2018-12-31-$178.41M-$159.12M$2.36M-$107.66M$316.11M
2017-12-31-$128.98M-$73.72M$62,000.00$17.11M$75.74M
2016-12-31-$109.58M-$84.39M$70,000.00$24.6M$51.16M
2015-12-31-$118.18M-$94.03M$1.42M
2014-12-31-$75.78M-$51.45M$2.83M
2013-12-31-$33.95M-$30.29M$57,000.00
2012-12-31-$15.89M-$15.51M$121,000.00
2011-12-31-$8.55M$376,000.00